Search Results

You are looking at 31 - 40 of 906 items for :

  • "radiation therapy" x
  • Refine by Access: All x
Clear All
Full access

Relationship Between Hemoglobin Levels and Quality of Life During Radiation Therapy Plus Concomitant or Sequential Chemotherapy in Patients With Cancer and Anemia Treated With Epoetin Alfa

Daniel Shasha, Pierre Cremieux, and Louis Harrison

patients undergoing radiation therapy . Semin Oncol 2001 ; 28 ( suppl 8 ): 54 – 59 . 4 Irvine D Vincent L Graydon JE . The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy: A comparison

Full access

Optimal Neoadjuvant Strategies for Locally Advanced Rectal Cancer by Risk Assessment and Tumor Location

Anurag Saraf, Hannah J. Roberts, Jennifer Y. Wo, and Aparna R. Parikh

Although early-stage rectal cancer is primarily treated with surgery, locally advanced rectal cancer (LARC), defined here as T3–4 or N-positive disease, generally involves multimodality therapy with surgery, radiation therapy (RT), and

Full access

YIA23-005: Early Interim Analysis of a Phase II Randomized Trial of Moderate Versus Ultra-Hypofractionated Post-Prostatectomy Radiation Therapy

William C. Jackson, Krithika Suresh, Daniel E. Spratt, and Robert T. Dess

Introduction: Salvage radiation therapy (SRT) is a standard treatment option for men with disease recurrence after radical prostatectomy. The burden of standard conventional or moderately hypofractionated schedules (4–8 weeks) may result in

Full access

HSR22-160: An Assessment of the Association Between Patient Race and Prior Authorization Program Determinations in the Context of Radiation Therapy for Breast Cancer

Adam C. Powell, Christopher T Lugo, Jeremy T Pickerell, James W Long, Amin J Mirhadi, and Bryan A Loy

Background : When a physician determines that a patient with breast cancer needs radiation therapy (RT), they submit an RT order to a prior authorization program which assesses guideline-concordance. An up-to-date, evidence-informed, rule

Full access

Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma

Matthias Holdhoff, Maciej M. Mrugala, Christian Grommes, Thomas J. Kaley, Lode J. Swinnen, Carlos Perez-Heydrich, and Lakshmi Nayak

-C, cytarabine; CSF, cerebrospinal fluid; HBV, hepatitis B virus; HCT/ASCT, high-dose chemotherapy and autologous stem cell transplant; HCV, hepatitis C virus; MTX, methotrexate; WBRT, whole-brain radiation therapy. Once the diagnosis is confirmed, treatment must

Full access

Spine Radiosurgery in the Management of Renal Cell Carcinoma Metastases

Neil K. Taunk, Daniel E. Spratt, Mark Bilsky, and Yoshiya Yamada

prognosis in patients with RCC. 3 , 4 Even with these advances in systemic treatment, radiation therapy (RT) continues to play a significant role in managing patients with metastatic disease to the brain and spine. RT is used for palliation of painful bone

Full access

Cancer-Related Fatigue

Ann M. Berger, Amy Pickar Abernethy, Ashley Atkinson, Andrea M. Barsevick, William S. Breitbart, David Cella, Bernadine Cimprich, Charles Cleeland, Mario A. Eisenberger, Carmen P. Escalante, Paul B. Jacobsen, Phyllis Kaldor, Jennifer A. Ligibel, Barbara A. Murphy, Tracey O'Connor, William F. Pirl, Eve Rodler, Hope S. Rugo, Jay Thomas, and Lynne I. Wagner

Overview Fatigue is a common symptom in patients with cancer and is nearly universal in those undergoing cytotoxic chemotherapy, radiation therapy, bone marrow transplantation, or treatment with biologic response modifiers. 1 – 10 The symptom

Full access

CLO22-083: Impact of Body Mass Index (BMI) on the Unplanned Need for Whole Breast Radiation Therapy (WBRT) Following Intra-Operative Electronic Brachyterapy for Early-Stage Breast Cancer

Barbara S Schwartzberg, A. M. Nisar Syed, and Craig Wengler

conserving surgery followed by WBRT are left with a treated breast which is smaller, asymmetric, and deformed. This change is lessened with use of single fraction 20 Gy intra-operative radiation therapy (IORT). A proportion of pts receiving IORT require

Full access

Early Versus Delayed Initiation of Salvage Androgen Deprivation Therapy and Risk of Prostate Cancer–Specific Mortality

Brandon A. Mahal, Ming-Hui Chen, Andrew A. Renshaw, Marian J. Loffredo, Philip W. Kantoff, and Anthony V. D'Amico

Background Prostate cancer (PC) is the most common noncutaneous malignancy in men, with 161,360 new cases and 26,730 deaths due to PC in 2017. 1 Although radical prostatectomy (RP) or radiation therapy (RT) with or without androgen

Full access

Treating Second Breast Events After Breast-Conserving Surgery for Ductal Carcinoma in Situ

Michael J. Hassett, Wei Jiang, Melissa E. Hughes, Stephen Edge, Sara H. Javid, Joyce C. Niland, Richard Theriault, Yu-Ning Wong, Deborah Schrag, and Rinaa S. Punglia

As the incidence of ductal carcinoma in situ (DCIS) has increased, so has the number of DCIS survivors. 1 Most patients with DCIS are treated with breast-conserving surgery (BCS). 2 Radiation therapy (RT) and antiestrogen therapy (AET) have been